Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
06/2003
06/26/2003US20030119125 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/26/2003US20030119124 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/26/2003US20030119123 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/26/2003US20030119122 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/26/2003US20030119121 Fusion proteins; binding to antibodies
06/26/2003US20030119120 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/26/2003US20030119119 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/26/2003US20030119118 Fusion proteins; binding to antibodies
06/26/2003US20030119117 Fusion proteins; binding to antibodies
06/26/2003US20030119116 Fusion proteins; binding to antibodies
06/26/2003US20030119115 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/26/2003US20030119114 Fusion proteins; binding to antibodies
06/26/2003US20030119113 Fusion proteins; binding to antibodies
06/26/2003US20030119112 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
06/26/2003US20030119111 G-protein coupled receptor, named 2871 receptor
06/26/2003US20030119110 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/26/2003US20030119109 Efficient 13C/15N double labeling of proteins in a methanol-utilizing strain (Mut+) of pichia pastoris
06/26/2003US20030119108 Method of making FGF-12 and KGF-2
06/26/2003US20030119106 Fusion proteins; binding to antibodies
06/26/2003US20030119105 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/26/2003US20030119104 Genetic engineered artificial chromosomes in plants, animals
06/26/2003US20030119103 Fusion proteins; binding to antibodies
06/26/2003US20030119102 Potassium channel interactors and uses therefor
06/26/2003US20030119101 Bactericides, fungicides; transporter proteins
06/26/2003US20030119100 DNA molecules encoding human nuclear receptor proteins
06/26/2003US20030119097 Anticancer agents; screening genetic engineered libraries
06/26/2003US20030119096 Detect, calibration binding of galanin; therapy for nervous system disorders
06/26/2003US20030119095 Novel nucleic acid sequences encoding human vesicle transport protein-like and residue rat-like polypeptides
06/26/2003US20030119094 Detection mutants; screening drug libraries; detecting antibiotics
06/26/2003US20030119092 Quantitative analysis; complexing with antibodies
06/26/2003US20030119089 Methods for controlling peptide solubility, chemically modified peptides, and stable solvent systems for producing same
06/26/2003US20030119086 Binding to antibodies, cell proliferation, cell differentiation
06/26/2003US20030119082 Fluorescence immunoassay
06/26/2003US20030119079 Using autoantibodies; vaccines
06/26/2003US20030119076 B7-like polynucleotides, polypeptides, and antibodies
06/26/2003US20030119055 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/26/2003US20030119047 Cancer-associated genes
06/26/2003US20030119044 Analyzing; detecting mutants; antiproliferative agents, autoimmune disease, antiinflamamtory agents, antiarthritic agents
06/26/2003US20030119039 Detection using antibodies
06/26/2003US20030119038 NARC1, novel subtilase-like homologs
06/26/2003US20030119024 Measurement variations in gene expression; calibrating patterns
06/26/2003US20030119023 Nucleic acid binding polypeptides characterized by flexible linkers connected nucleic acid binding modules
06/26/2003US20030119018 Novel polynucleotides
06/26/2003US20030119013 Identification of essential genes of Aspergillus fumigatus and methods of use
06/26/2003US20030119001 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/26/2003US20030118995 Novel Rab proteins
06/26/2003US20030118993 Nucleic acid which is upregulated in human tumor cells, a protein encoded thereby and a process for tumor diagnosis
06/26/2003US20030118992 ABC transporter
06/26/2003US20030118991 Determination cancer sensitivity; monitoring radiation exposure; cloning nucleic acids; polymerase chain reactions
06/26/2003US20030118990 Novel estrogen-regulated G protein gamma subunit: compositions and methods of use
06/26/2003US20030118988 Brain and heart cyclic nucleotide gated ion channel compounds and uses thereof
06/26/2003US20030118612 G-CSF conjugates
06/26/2003US20030118611 Epitopes confirmed to be recognized by T-cells derived from herpetic lesions or uterine cervix; vaccination
06/26/2003US20030118609 Administering a multimer of a human papillomavirus protein that is truncated at its amino terminus for immunization
06/26/2003US20030118608 Comprising Lelystad Agent in a live, attenuated, dead, or recombinant form
06/26/2003US20030118604 Comprising the 2-45 amino acid sequence of the N-terminal end of the core or nucleocapsid (p21) protein of the hepatitis C virus (HCV), excluding any protein or peptide compound comprising the N-terminal end
06/26/2003US20030118603 Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use
06/26/2003US20030118602 Peptides and immunologically functional variants thereof which are immunogenic epitopes recognized by CD8+ class I major histocompatibility complex restricted cytotoxic T-lymphocytes of patients harboring latent human cytomegalovirus infection
06/26/2003US20030118601 FIV vaccine
06/26/2003US20030118600 Transfer compounds, production and use thereof
06/26/2003US20030118599 Comprising lung tumor polypeptides, immunogenic portions thereof, polynucleotides that encode such polypeptides, antigen presenting cells that expresses such polypeptides, and T cells specific for cells expressing such polypeptides
06/26/2003US20030118596 Fusion proteins economically synthesized in plants at high levels by biologically contained tobamoviruses; use as antigens for inducing production of antibodies or as vaccine antigens for induction of immunity against parvovirus
06/26/2003US20030118594 Stable formulations of mhc-peptide complexes
06/26/2003US20030118590 Lantibiotic polypeptides; useful as antimicrobials in antibiotic pharmaceutical preparation and as antimicrobial or antiseptic dentifrice
06/26/2003US20030118589 Growth factor binding molecules
06/26/2003US20030118586 G protein coupled receptor protein, production and use thereof
06/26/2003US20030118579 Sparc-related proteins
06/26/2003US20030118573 MB-1 analogs and uses thereof
06/26/2003US20030118568 Viral stealth technology to prevent T cell-mediated rejection of xenografts
06/26/2003US20030118557 Axon repair
06/26/2003US20030118556 Transducing neuron with gene; muscular disorders
06/26/2003US20030118552 Targeted retrograde gene delivery for neuronal protection
06/26/2003US20030118551 Modified viral surface proteins for binding to extracellular matrix components
06/26/2003US20030118546 Genetic engineering; polypeptides; antitumor agent
06/26/2003US20030118510 Immobilization of insulin; antidiabetic agents
06/26/2003US20030118509 Novel methods of diagnosing colorectal cancer, compositions, and methods of screening for colorectal cancer modulators
06/26/2003US20030118506 Cardiovascular disorders, vision defects; isolated nucleic acid
06/26/2003CA2510654A1 Antigens for actinobacillus pleuropneumoniae and methods thereof
06/26/2003CA2478313A1 41 human secreted proteins
06/26/2003CA2471777A1 Novel death associated proteins of the thap family and related par4 pathways involved in apoptosis control
06/26/2003CA2470685A1 Compositions, methods and kits relating to thrombin degradation resistant fibroblast growth factor-1
06/26/2003CA2470419A1 Growth factor modified protein matrices for tissue engineering
06/26/2003CA2470026A1 Clonal myeloma cell lines useful for manufacturing proteins in chemically defined media
06/26/2003CA2469984A1 Process for the purification and/or isolation of biologically active granulocyte colony stimulating factor
06/26/2003CA2469812A1 Mutants of human insulin-like growth factor binding protein-3 (igfbp-3) and uses thereof
06/26/2003CA2469799A1 Use of a lysolipid for the preparation of a composition for transfection of a polynucleotide into a cell
06/26/2003CA2469785A1 Adeno-associated virus (aav) serotype 8 sequences, vectors containing same, and uses therefor
06/26/2003CA2468790A1 Chemokine mutants acting as chemokine antagonists
06/26/2003CA2468690A1 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use
06/26/2003CA2467732A1 Novel human proteins, polynucleotides encoding them and methods of using the same
06/26/2003CA2459661A1 Insect g protein-coupled receptor genes and uses thereof
06/26/2003CA2446292A1 Nucleic acid-associated proteins
06/26/2003CA2412627A1 Genes and proteins involved in the biosynthesis of lipopeptides
06/25/2003EP1321772A1 Method and kit for detecting, or determining, 3,4-methylenedioxymethamphetamine
06/25/2003EP1321533A2 Nucleic acid, probe comprising the nucleic acid and screening method using the probe
06/25/2003EP1321526A2 Adenovirus-mediated gene transfer to cardiac and vascular smooth muscle
06/25/2003EP1321525A2 Fruit ripening-related genes
06/25/2003EP1321522A1 Promoting cell survival by inhibiting BARD1 apoptotic activity
06/25/2003EP1321476A2 Binding protein
06/25/2003EP1321475A1 Gene useful for diagnosis and treatment of aplasia of corpus callosum and aspermatogensis and use thereof
1 ... 1581 1582 1583 1584 1585 1586 1587 1588 1589 1590 1591 1592 1593 1594 1595 1596 1597 1598 1599 1600 1601 ... 2916